These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Maltol-derived ruthenium-cymene complexes with tumor inhibiting properties: the impact of ligand-metal bond stability on anticancer activity in vitro. Kandioller W; Hartinger CG; Nazarov AA; Bartel C; Skocic M; Jakupec MA; Arion VB; Keppler BK Chemistry; 2009 Nov; 15(45):12283-91. PubMed ID: 19821465 [TBL] [Abstract][Full Text] [Related]
43. Anticancer activity of tetracationic arene ruthenium metalla-cycles. Barry NP; Edafe F; Therrien B Dalton Trans; 2011 Jul; 40(27):7172-80. PubMed ID: 21660364 [TBL] [Abstract][Full Text] [Related]
44. Synthesis and cytotoxic activities of organometallic Ru(II) diamine complexes. Kavukcu SB; Şahin O; Seda Vatansever H; Kurt FO; Korkmaz M; Kendirci R; Pelit L; Türkmen H Bioorg Chem; 2020 Jun; 99():103793. PubMed ID: 32278205 [TBL] [Abstract][Full Text] [Related]
45. Design, synthesis and biological evaluation of novel 4-anilinoquinazolines with C-6 urea-linked side chains as inhibitors of the epidermal growth factor receptor. Zhang X; Peng T; Ji X; Li J; Tong L; Li Z; Yang W; Xu Y; Li M; Ding J; Jiang H; Xie H; Liu H Bioorg Med Chem; 2013 Dec; 21(24):7988-98. PubMed ID: 24183742 [TBL] [Abstract][Full Text] [Related]
46. Metal complexes as DNA intercalators. Liu HK; Sadler PJ Acc Chem Res; 2011 May; 44(5):349-59. PubMed ID: 21446672 [TBL] [Abstract][Full Text] [Related]
47. Amide linkage isomerism as an activity switch for organometallic osmium and ruthenium anticancer complexes. van Rijt SH; Hebden AJ; Amaresekera T; Deeth RJ; Clarkson GJ; Parsons S; McGowan PC; Sadler PJ J Med Chem; 2009 Dec; 52(23):7753-64. PubMed ID: 19791745 [TBL] [Abstract][Full Text] [Related]
50. (Arene)Ru(II) complexes of epidermal growth factor receptor inhibiting tyrphostins with enhanced selectivity and cytotoxicity in cancer cells. Biersack B; Zoldakova M; Effenberger K; Schobert R Eur J Med Chem; 2010 May; 45(5):1972-5. PubMed ID: 20149940 [TBL] [Abstract][Full Text] [Related]
54. Arene control over thiolate to sulfinate oxidation in albumin by organometallic ruthenium anticancer complexes. Hu W; Luo Q; Ma X; Wu K; Liu J; Chen Y; Xiong S; Wang J; Sadler PJ; Wang F Chemistry; 2009 Jul; 15(27):6586-94. PubMed ID: 19533706 [TBL] [Abstract][Full Text] [Related]
55. Photocontrolled DNA binding of a receptor-targeted organometallic ruthenium(II) complex. Barragán F; López-Senín P; Salassa L; Betanzos-Lara S; Habtemariam A; Moreno V; Sadler PJ; Marchán V J Am Chem Soc; 2011 Sep; 133(35):14098-108. PubMed ID: 21797210 [TBL] [Abstract][Full Text] [Related]